Rotavirus Gastroenteritis Clinical Trial
Official title:
Phase III, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Live Attenuated Bovine-Human Rotavirus Reassortant Pentavalent Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Healthy Indian Infants
This is a Phase 3 multicentre, randomized, double blind, placebo-controlled study to determine the effectiveness of the rotavirus vaccine.
The hypothesis is that a three dose series of BRV-PV administered orally to healthy Indian infants, with the initial dose given at 6-8 weeks of age and followed by vaccinations at monthly intervals, will significantly reduce the incidence of severe rotavirus gastroenteritis (SRVGE). Duration of follow-up is until aged 2 years of each enrolled child. The study is powered to detect vaccine efficacy significantly greater than 10% (95% confidence interval lower bound > 10%) if the true vaccine efficacy is 50% or higher. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01575197 -
Evaluation of the Human Rotavirus Vaccine at Varying Schedules and Doses in Rural Ghana
|
Phase 4 | |
| Completed |
NCT01202201 -
A Retrospective Survey of the Burden of Rotavirus Gastroenteritis (RV GE) and Nosocomial RV GE in Japan
|
N/A | |
| Completed |
NCT00953056 -
A Study of V260 in Healthy Chinese Adults, Children and Infants (V260-028)(COMPLETED)
|
Phase 1 | |
| Completed |
NCT00737503 -
Introduction of an Oral Live Human Rotavirus (Rotarix) Vaccine in Matlab
|
Phase 4 | |
| Completed |
NCT04185545 -
Efficacy, Safety and Immunogenicity of Rotavirus RV3 Vaccine (Bio Farma) in Neonates
|
Phase 3 | |
| Completed |
NCT03474055 -
Study on Liquid Bovine Rotavirus Pentavalent Vaccine (LBRV-PV) to Evaluate Lot-to-Lot Consistency and to Compare Non-Inferiority With ROTASIIL (Lyophilized BRV-PV) in Healthy Infants in India
|
Phase 2/Phase 3 | |
| Completed |
NCT01236066 -
Impact of Rotavirus Vaccination on Hospitalisations for Rotavirus Gastroenteritis in Children Aged <5 Years in Australia
|
N/A | |
| Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
| Completed |
NCT02584816 -
Phase III Study on Rotavirus Vaccine to Evaluate Lot-to-lot Consistency and Interference With Routine UIP Immunization
|
Phase 3 | |
| Completed |
NCT02062385 -
Efficacy, Safety, and Immunogenicity of V260 in Healthy Chinese Infants (V260-024)
|
Phase 3 | |
| Completed |
NCT01177657 -
Study to Evaluate the Effectiveness of Rotarix™ Against Severe Gastroenteritis Among Hospitalized Children in Brazil
|
N/A | |
| Completed |
NCT00740935 -
Impact of Systematic Infants Vaccination Against Rotavirus on Gastroenteritis Hospitalization: a Prospective Study in Brest District, France.
|
Phase 4 | |
| Completed |
NCT01265355 -
Community Based Prevention of Rotavirus Gastroenteritis by a Functional Food Supplement
|
Phase 2/Phase 3 | |
| Completed |
NCT00169455 -
Assess the Immunogenicity of the Human Rotavirus (HRV) Vaccine After Reconstitution Without Buffering Agent; & Evaluate the Immunogenicity, Reactogenicity & Safety of the Vaccine After Storage for 7 d at 37°C Following 2 Doses in Healthy Infants
|
Phase 3 | |
| Completed |
NCT04819412 -
To Determine the Safety and Efficacy of Liquid ROTAVAC 5C Vaccine Against Childhood Diarrhea Caused by Rotavirus
|
Phase 3 | |
| Completed |
NCT02728869 -
Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05958771 -
The Efficacy of Three Doses of Live Attenuated, Oral Rotavirus Vaccine 116E
|
Phase 3 | |
| Recruiting |
NCT01061658 -
Safety and Immunogenicity Study of the Tetravalent Rotavirus Vaccine
|
Phase 1/Phase 2 | |
| Completed |
NCT01508533 -
Epidemiology of Rotavirus Infection in North India Community
|
N/A | |
| Completed |
NCT01026779 -
Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island
|